Configuring the users of new HIV-prevention technologies
The case of HIV pre-exposure prophylaxis
Bibliographic Data
| ID | 15098558 |
|---|---|
| Authors | Martin Holt (0000-0002-2586-8274, National Centre for Social Research, corresponding author) |
| Year | 2015 |
| Volume | 17 |
| Issue | 4 |
| Pages | 428-439 |
| Publication date | 2015-04-21 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Culture Health & Sexuality (JOURNAL) |
| Journal identifiers | ISSN: 1369-1058 • E-ISSN: 1464-5351 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/13691058.2014.960003 |
| PMID | 25270549 |
| OpenAlex | W2057205765 |
| Language | EN |
| Citations received | 29 |
| References cited | 29 |
HIV pre-exposure prophylaxis (PrEP) is a prevention technology that involves prescribing antiretroviral drugs to HIV-negative people to protect them from infection. This paper considers how the development of the technology has necessitated the parallel configuration of its users, and how this process has affected the perception and uptake of the technology. In designing a technology, potential users are typically defined, enabled and constrained, partly to create a target population (or market) for the technology, but also to reassure people that it can be used safely and effectively. This process may or may not be helpful for the uptake and use of the technology. Published research on PrEP indicates that while the technology was under trial, the primary focus was on the 'at-risk' subject in need of PrEP, with little or no consideration of the other qualities necessary for successful use. Post-trial accounts of PrEP have begun to outline desirable qualities of successful PrEP use, such as caution, compliance and being organised. It appears that the PrEP user was only partially configured during the technology's development, and the initial focus on risk has done little to counter fears of the technology, which may partially account for its slow uptake
Business · Environmental health · Family medicine · Internet privacy · Men who have sex with men · Perception · Population · Pre-exposure prophylaxis · Technology development · Computer Science · Engineering · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Psychology · Sex work and related issues
The People vs the NHS
Can a pill preventHIV? Negotiating the biomedicalisation ofHIVprevention
Reasons for not Using HIV Pre-Exposure Prophylaxis (PrEP) among Gay and Bisexual Men in Australia
HIV prevention and the impact of It’s a Sin in Scotland
A wager on the future
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
HIV Both Starts and Stops with Me’
Public health’s social contract
Understanding how PrEP is made successful
‘On December 1, 2015, sex changes. Forever’
Gay and Bisexual Men’s Perceptions of Pre-exposure Prophylaxis (PrEP) in a Context of High Accessibility
Promoting ‘Equitable Access’ to PrEP in Australia
Active-offer PrEP for HIV prevention
Is HIV prevention creating new biosocialities among gay men? Treatment as prevention and pre-exposure prophylaxis in Canada
Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM
PrEP (HIV pre-exposure prophylaxis) and its possibilities for clinical practice
Discipline for pleasure
Styles of thought in healthcare governance
Configuring the PrEP user
Studying the “sexuality-health-technology nexus”
Moral practices shaping HIV disclosure among young gay and bisexual men living with HIV in the context of biomedical advance
WTF is PrEP?’
Risk, safety and sex among male PrEP users
Clinician imaginaries of HIV PrEP users in and beyond the gay community in Australia
The limits of promoting pleasure
HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia
The social meanings of PrEP use - A mixed-method study of PrEP use disclosure in Antwerp and Amsterdam
The 'Informed Matter' of Gay and Bisexual Men's (Potential) Use of HIV Antiretrovirals to Prevent Covid-19
Body/Selves and Beyond
Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco
How Acceptable are Antiretrovirals for the Prevention of Sexually Transmitted HIV?
Sexual Risk Behaviors and Acceptability of HIV Pre-Exposure Prophylaxis Among HIV-Negative Gay and Bisexual Men in Serodiscordant Relationships
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
How Users Matter
Intervention by Invitation
Reassembling the Social
HIV Providers’ Perceived Barriers and Facilitators to Implementing Pre-exposure Prophylaxis in Care Settings
Blockage and flow
Making prevention public
Sexual Partnerships and Considerations for HIV Antiretroviral Pre-Exposure Prophylaxis Utilization Among High-Risk Substance Using Men Who Have Sex with Men
Resisting medicines
Configuring the User
HIV Prevention Rationalities and Serostatus in the Risk Narratives of Gay Men
| Unique citing works | 29 |
|---|---|
| Citations per year | 2,9 |
| Citation span | 2016 - 2026 (11) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 27 |